Yikon Genomics Funding: $39M Raised, Series D (2017)
Yikon Genomics is based in Shanghai, China. It has raised $39M in total funding. Latest round: Series D.
Yikon Genomics funding overview
Yikon Genomics is based in Shanghai, China. Yikon Genomics has raised $39M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series D announced in January 2017. The round record for Yikon Genomics runs through 2017; nothing later has been disclosed. Investors on record include Guangzhou Kingmed, Yuexiu Industrial Fund, Shenzhen New Industry Venture Capital, Frontline Bioventures, Yuexiu's Industrial Fund. 5 distinct backers are named across the disclosed rounds.
Yikon Genomics at a glance
Total raised
$39M
Latest round
Series D
Latest round date
January 2017
Headquarters
Shanghai, China
Notable investors
Guangzhou Kingmed, Yuexiu Industrial Fund, Shenzhen New Industry Venture Capital, Frontline Bioventures, Yuexiu's Industrial Fund
Frequently asked about Yikon Genomics funding
How much has Yikon Genomics raised?
Yikon Genomics has raised $39M in total disclosed funding across the rounds on record.
Who has invested in Yikon Genomics?
Guangzhou Kingmed, Yuexiu Industrial Fund, Shenzhen New Industry Venture Capital, Frontline Bioventures, Yuexiu's Industrial Fund are named among the investors backing Yikon Genomics.
What was the latest Yikon Genomics funding round?
The most recent disclosed round is a Series D, announced in January 2017.
Where is Yikon Genomics based?
Yikon Genomics is based in Shanghai, China.
When did Yikon Genomics last raise?
The last disclosed Yikon Genomics round closed in January 2017 at Series D.
Totals shown for Yikon Genomics aggregate every disclosed round on file. To see how that compares, browse the companies in Shanghai and the investors behind them below.
